Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration finalized an expedited regulatory pilot that will pair drug companies with qualified research institutions to shorten the path to first-in-human clinical …
FDA Opens Expedited Drug Trial Pilot to Cut Development Delays Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Scientific Officer Jeffrey Martini will address evidence gaps and regulatory barriers affecting drug repurposing at an Aug. 5 FDA public workshop …
Palvella Executive to Address FDA Drug Repurposing Barriers Read More
NEWTOWN, PA — Traws Pharma (Nasdaq: TRAW) is advancing development of a broad-spectrum antiviral combination designed to target multiple high-risk viral diseases, including hantavirus, Ebola, and Lassa fever, as the …
Traws Advances Broad-Spectrum Antiviral as Outbreak Risks Grow Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has proposed reducing animal testing requirements for certain cancer therapies, a shift that could lower development costs and shorten preclinical timelines …
FDA Moves to Cut Animal Testing for Some Cancer Drugs Read More
WASHINGTON, D.C. — Federal regulators say efforts to reduce animal testing in drug development are advancing, with the Food and Drug Administration reporting early progress on a plan aimed at …
FDA Push to Cut Animal Testing Shows Early Progress Read More
GLENOLDEN, PA — The Charcot-Marie-Tooth Association has committed $100,000 to EverTree Bio, deepening its push to turn early scientific promise into potential treatments for Charcot-Marie-Tooth disease Type 1A, the most …
$100,000 Bet on Breakthrough: CMTA Backs Early CMT1A Drug Hope Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the successful transfer and rewrite of all its intellectual property protections to cover a newly developed crystalline form of its lead drug …
Annovis Bio Secures Full Patent Protection for New Crystal Form of Alzheimer’s Drug Buntanetap Read More
BERWYN, PA — Specialty pharmacy and healthcare services firm AscellaHealth is spotlighting its role as the HUB partner for Abeona Therapeutics (Nasdaq: ABEO) in the launch and commercialization of ZEVASKYN™, …
AscellaHealth Drives Patient-Centric Launch Support for Groundbreaking Gene Therapy ZEVASKYN Read More
WASHINGTON, D.C. — In a landmark move to improve transparency and modernize regulatory processes, the U.S. Food and Drug Administration (FDA) has published more than 200 complete response letters (CRLs) …
FDA Publishes Over 200 Complete Response Letters to Increase Drug Approval Transparency Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has unveiled the Commissioner’s National Priority Voucher (CNPV) program, aiming to streamline the drug approval process and address critical health …
FDA Introduces Priority Voucher Program to Accelerate Drug Approvals Read More